Bacterin Names New President

Bacterin International Holdings Inc. has named of Robert (Bob) Di Silvio as new president of the company. Di Silvio brings over 30 years of experience serving in executive management positions in the medical industry, overseeing sales and marketing efforts in the management of medical sales operations.

“I had the privilege of working with Bob when we were both involved with other companies. Bob has a distinguished track record of success in the medical device industry, managing sales and marketing operations with significant growth achievements,” said CEO Dan Goldberger. “We are fortunate to have Bob join our management team in this important role; he brings unrivaled experience and leadership to the company and will play a critical role in our growth.”

Prior to joining Bacterin, Di Silvio served as senior vice president and general manager of the Americas region for Lumenis since January 2012, and prior to that role, as senior vice president and general manager, Lumenis North America Region. Di Silvio previously served as president and CEO of Pyng Medical Inc.; as vice president global sales and marketing of Safe Life; as vice president of U.S. Field Operations Physio-Control Division of Medtronic Inc.; and as vice president, U.S. Field Operations of Coherent Medical Group. Di Silvio currently serves as a member of the board of directors of Pyng Medical Corp. He holds a bachelor’s degree in economics and organic chemistry and a master’s degree in biochemistry from the University of Connecticut, and he also completed three years at the University of Rome School of Medicine, Italy.

In his new role, Di Silvio will be responsible for management of sales, marketing and business development.

Based in Belgrade, Mont., Bacterin makes bone graft material and coatings for medical applications.